Streptococcus Pneumoniae Infection Clinical Trial
Official title:
Prevention of Pneumococcal Infections: Impact Collaborative Medico-pharmaceutical Care Structured to Improve Vaccination Coverage of Patients at Risk.
In France, Streptococcus pneumoniae is the leading agent bacterial involved in community lung disease and meningitis. The frequency of these infections and their mortality increase significantly in those at risk such as patients with certain chronic diseases, immunocompromised or on immunosuppressive therapy. This population, despite regular monitoring, has a limited pneumococcal vaccine coverage of around 20%. By carrying out a reconciliation of treatments upon admission to hospital, the clinical pharmacist can detect those without up to date pneumococcal vaccination status. The goal of this management is to make the patient aware of the need for vaccination and organization upon return home. Thus, this limited pneumococcal vaccination coverage would benefit from intervention by regional clinical pharmacy activities. The study investigators want to study the impact of a structured medico-pharmaceutical collaboration on pneumococcal vaccination of patients with risk on discharge from hospital. The investigators hypothesize that this collaboration in patients at risk of infection with pneumococcus could significantly increase their anti-pneumococcal vaccination coverage
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05017519 -
Epidemiology and Household Transmission of Streptococcus Pneumoniae and Respiratory Syncytial Virus
|
||
| Recruiting |
NCT05759520 -
Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants
|
Phase 3 | |
| Completed |
NCT05361499 -
A Controlled Human Pneumococcal Infection Model (PIM) Study
|
N/A | |
| Active, not recruiting |
NCT03489018 -
The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants
|
Phase 4 | |
| Completed |
NCT03696303 -
Determination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger With Community Acquired Pneumonia in Guatemala
|
||
| Active, not recruiting |
NCT03102840 -
Understanding Pneumococcal Carriage and Disease 2017-2020
|
||
| Completed |
NCT00189020 -
Effect of Two Versus Three Pneumococcal Conjugate Vaccinations
|
Phase 3 | |
| Completed |
NCT02037984 -
Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04944719 -
Pneumococcal Nasopharyngeal Colonization as Predictor of Community-Acquired Pneumonia (CAP) in Adults With Chronic Diseases.
|
||
| Completed |
NCT03384589 -
CIRN Pneumococcal Conjugate Vaccine 1 vs. 2 Dose Priming Study
|
Phase 2/Phase 3 |